Invest early for a piece of the action in China
This article was originally published in Clinica
Executive Summary
Valued at $1,000 million in 1995 and growing at an estimated average of 30%, China's medical device market is the largest in Asia. However, most US firms doing business in China report that "the competition is stiff, that the multi-layered bureaucracy can be frustrating and expensive to deal with, and that profits are small", says US industry association HIMA in its newly-published 1996 Emerging Market Report.
You may also be interested in...
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.